Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lassmann

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 19, 2021
Toward a Patient-Specific Traceable Quantification of SPECT/CT-Based Radiopharmaceutical DistributionsAnna-Lena Theisen, Michael Lassmann, Johannes Tran-Gia
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Impact of 131I diagnostic activities on the biokinetics of thyroid remnantsMichael Lassmann, Markus Luster, Heribert Hänscheid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 25, 2022
An EANM position paper on the application of artificial intelligence in nuclear medicineRoland Hustinx, Jan Pruim, Michael Lassmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2019
What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular RadiotherapyJohannes Tran-Gia, Maikol Salas-Ramirez, Michael Lassmann
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2016
Standardization of administered activities in paediatric nuclear medicine: the EANM perspectiveMichael Lassmann, Uta Eberlein, Egesta Lopci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSHMichael Lassmann, Heribert Hänscheid, Christoph Reiners, et al.
Hormones (Athens, Greece)|December 7, 2007
Thyroid cancer in childhood: management strategy, including dosimetry and long-term resultsMarkus Luster, Michael Lassmann, Lutz S Freudenberg, et al.
Scientific Reports|February 4, 2018
DNA damage in leukocytes after internal ex-vivo irradiation of blood with the α-emitter Ra-223Sarah Schumann, Uta Eberlein, Razan Muhtadi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Dosimetry Software for Theranostic Applications: Current Capabilities and Future ProspectsAdam L Kesner, Julia Brosch-Lenz, Jonathan Gear, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 20, 2022
Is a single late SPECT/CT based kidney <sup>177</sup>Lu-dosimetry superior to hybrid dosimetry with sequential multiple time-point whole-body planar scans in combination with an early SPECT/CT?Seval Beykan, Johannes Tran-Gia, Svend Borup Jensen, et al.
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 19, 2021
Toward a Patient-Specific Traceable Quantification of SPECT/CT-Based Radiopharmaceutical DistributionsAnna-Lena Theisen, Michael Lassmann, Johannes Tran-Gia
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Impact of 131I diagnostic activities on the biokinetics of thyroid remnantsMichael Lassmann, Markus Luster, Heribert Hänscheid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 25, 2022
An EANM position paper on the application of artificial intelligence in nuclear medicineRoland Hustinx, Jan Pruim, Michael Lassmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2019
What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular RadiotherapyJohannes Tran-Gia, Maikol Salas-Ramirez, Michael Lassmann
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2016
Standardization of administered activities in paediatric nuclear medicine: the EANM perspectiveMichael Lassmann, Uta Eberlein, Egesta Lopci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSHMichael Lassmann, Heribert Hänscheid, Christoph Reiners, et al.
Hormones (Athens, Greece)|December 7, 2007
Thyroid cancer in childhood: management strategy, including dosimetry and long-term resultsMarkus Luster, Michael Lassmann, Lutz S Freudenberg, et al.
Scientific Reports|February 4, 2018
DNA damage in leukocytes after internal ex-vivo irradiation of blood with the α-emitter Ra-223Sarah Schumann, Uta Eberlein, Razan Muhtadi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Dosimetry Software for Theranostic Applications: Current Capabilities and Future ProspectsAdam L Kesner, Julia Brosch-Lenz, Jonathan Gear, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 20, 2022
Is a single late SPECT/CT based kidney <sup>177</sup>Lu-dosimetry superior to hybrid dosimetry with sequential multiple time-point whole-body planar scans in combination with an early SPECT/CT?Seval Beykan, Johannes Tran-Gia, Svend Borup Jensen, et al.
Pageof 17